Adolor Seeks New Entereg Partner; Asks FDA To Weigh In On Chronic Use
This article was originally published in The Pink Sheet Daily
Executive Summary
GSK returns rights to alvimopan in outpatient settings; partnership continues for approved hospital use.
You may also be interested in...
Nektar Dips Into AstraZeneca's Deep Pockets With OIC Deal
As Nektar reinvents itself, the specialty drug developer gets multi-million dollar validation from AstraZeneca in deal for NKTR-118.
Nektar Dips Into AstraZeneca's Deep Pockets With OIC Deal
As Nektar reinvents itself, the specialty drug developer gets multi-million dollar validation from AstraZeneca in deal for NKTR-118.
Nektar Starts Major Push In Opioid-Induced Constipation Space
Biotechs that manage solid proof of concept in the challenging but potentially high-value area of opioid-induced constipation might find a receptive partnering audience in a variety of pharma quarters